-+ 0.00%
-+ 0.00%
-+ 0.00%

Novartis CEO: Rembutinib's sales are still likely to reach $4 billion or more.

Zhitongcaijing·10/27/2026 07:01:33
Listen to the news
Novartis CEO: Rembutinib's sales are still likely to reach $4 billion or more.